Skip to main content
. 2021 Feb 13;44(8):1553–1570. doi: 10.1007/s40618-020-01486-0

Table 3.

Explanatory summary of the results

Endocrine gland/system Infection Pathological features Endocrine function
Thyroid SARS

Derangement of the follicular architecture [78]

High levels of apoptosis (by Tunel), in both follicular epithelium and in interfollicular region [78]

Interfollicular fibrosis [78]

Absence of calcitonin-positive cells [78]

FT3 and FT4 levels significantly lower than control group [79]

FT3 and FT4 levels decreased, respectively, by 94% and 46%, during the acute phase of illness [79]

FT3 and FT4 levels decreased, respectively, by 90% and 38% during the convalescence phase of illness [79]

COVID-19

No abnormalities in thyroid follicular cells [67]

Interstitial lymphocytic infiltration [67]

During recovery, TSH and FT3 levels were significantly lower in patients than in healthy subjects [82]

Decrease in TSH and TT3 or FT3 levels positively correlated to the infection severity [76, 8285]

Mild reductions of TSH and FT4 in admission to hospital [86]

Normalization of thyroid function tests at follow-up post hospital discharge [82, 84, 86]

Clinical, biochemical and ultrasound evidences of subacute thyroiditis during recovery phase [8792]

Low TSH and FT3 levels associated with normal/elevated FT4 [93]

Hypothalamus/Pituitary axis SARS

Focal cell damage and reduction of TSH-positive, ACTH-positive and GH-positive cells by IHC [71]

Increased number of PRL-, LH-e and FSH-positive cells by IHC [71]

Detection of SARS-CoV-1 genome sequences in hypothalamus/pituitary cells from autoptic tissues by in situ Hybridization and RT-PCR [6870]

83% of patients had central hypocortisolism with concomitant low or inappropriately normal ACTH levels [74]

Increased PRL, LH, FSH serum levels in male patients [72, 73]

COVID-19 Presence of SARS-CoV-2 in the cerebrospinal fluid of patients [75]

Decrease of GH and IGFBP-3 levels [76]

34% of patients displayed isolated low TSH values [82]

Adrenal Gland SARS

Thrombosis and vasculitis in the adrenal vessels [65, 70]

Hybridization in situ detected SARS-CoV-1 genome sequences in autoptic tissues [68]

COVID-19

Infiltration of CD3+ and CD8+ lymphocytes in different layers of cortex and in surrounding tissue [94]

Small groups of proliferating cells with enlarged clear nuclei [94]

Predominant vascular damage localized to the adrenals rather than the other organs [95, 96]

Acute fibrinoid necrosis of adrenal arteriolae both in the parenchyma and capsule [96].

Focal inflammation [95]

Adrenal parenchymal infarcts or thrombosis [95, 96]

Reports of acute bilateral adrenal hemorrhage and consequent acute adrenal failure [97, 98]
Ovary SARS No detection SARS-CoV-1 RNA polymerase by immunohistochemistry and in situ hybridization [69]
COVID-19 / /
Testis SARS

Extensive destruction of testicular germ cells [105, 106]

Rare spermatozoa in the epithelium and lumen of seminiferous tubules [105, 106]

Peritubular fibrosis [105, 106]

Massive leukocyte infiltration and IgG presence [105, 106]

Conflicting evidence about the presence of SARS-CoV-1 RNA in testicular cells by in situhybridization [69, 107]

Reduced testosterone levels in male patients [72, 73]

Increased levels of LH and FSH in SARS males [72, 73]

COVID-19

Sertoli cells: variable degree of swelling, vacuolation and cytoplasmic rarefaction, detachment from tubular basement membranes and sloughing into lumens of the intratubular cell mass [108]

Reduced number of Leydig cells [108]

Infiltrates of lymphocytes, macrophages and histiocytes in the interstitium [108110]

Thinning of seminiferous tubules with a significant high number of apoptotic cells and IgG inside [110]

Oligozoospermia and significant increase of semen leucocyte number in 39.1% and 60.9% of COVID-19 patients, respectively [110]

Conflicting evidences about the presence of SARS-CoV-2 RNA in testicular cells by RT-PCR [108, 110]

Conflicting evidence about the presence of SARS-CoV-2 RNA in semen by RT-PCR [112116]

Significant increase in serum LH, while T/LH and decrease of FSH/LH ratios [111]

Not significant changes in serum testosterone levels between patients and control groups [111]